What this study adds
DMO

In this analysis, we assessed how much time above various different VA thresholds can be achieved in DMO, focusing on a threshold of a best-corrected VA letter score ≥69 (approximate Snellen equivalent 20/40), chosen to align with the majority of global vision requirements for driving.DRCR.net Protocol T data comparing treatment response to three anti-VEGF agents were analysed post hoc and showed time in range above best-corrected VA letter score ≥69 was 41 weeks over Year 1 with intravitreal aflibercept, compared with 37 weeks for bevacizumab and 38 weeks for ranibizumab.Time in range may be another way to describe vision outcomes and potential impact on vision-related functions over time for patients with DMO and is a concept transferable to other outcomes and retinal conditions.